NTRK1 and colorectal carcinoma: In a study by Huang et al., upregulated miR-148a enhanced chemoradiosensitivity and promoted apoptosis of CRC cells by targeting the MET proto-oncogene, receptor tyrosine kinase (c-Met), in vitro and in vivo [113].